Celldex Therapeutics Earnings Estimate

CLDX Stock  USD 26.76  1.38  4.90%   
By analyzing Celldex Therapeutics' earnings estimates, investors can diagnose different trends across Celldex Therapeutics' analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Celldex Therapeutics is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Celldex Therapeutics is projected to generate -0.599725 in earnings per share on the 31st of December 2024. Celldex Therapeutics earnings estimates module stress-tests analyst consensus about projected Celldex Therapeutics EPS (Earning Per Share) to derive its highest and lowest estimates based on its historical volatility. Many public companies, such as Celldex Therapeutics, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm.

Celldex Therapeutics Revenue Breakdown by Earning Segment

By analyzing Celldex Therapeutics' earnings estimates, investors can diagnose different trends across Celldex Therapeutics' analyst sentiment over time as well as compare current estimates against different timeframes. Gross Profit Margin is likely to rise to 0.59 in 2024, despite the fact that Gross Profit is likely to grow to (105.6 M).
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Celldex Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
For more information on how to buy Celldex Stock please use our How to Invest in Celldex Therapeutics guide.

Celldex Therapeutics Earnings per Share Projection vs Actual

About Celldex Therapeutics Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Celldex Therapeutics earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Celldex Therapeutics estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Celldex Therapeutics fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings-1.4 B-1.3 B
Retained Earnings Total Equity-1 B-1.1 B
Earnings Yield(0.07)(0.08)
Price Earnings Ratio(13.59)(14.27)
Price Earnings To Growth Ratio(1.19)(1.13)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Celldex Stock Analysis

When running Celldex Therapeutics' price analysis, check to measure Celldex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celldex Therapeutics is operating at the current time. Most of Celldex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Celldex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celldex Therapeutics' price. Additionally, you may evaluate how the addition of Celldex Therapeutics to your portfolios can decrease your overall portfolio volatility.